Biotech · Private company
Hope Biosciences LLC
Track this companyFree. Adds Hope Biosciences LLC to your Dealase workspace and tells you when its record changes.
Clinical trials72 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Allogeneic HB-adMSCsPhase 2 · Acute Kidney InjuryClinicalTrials.gov · fetched Nov 12, 2026
- Autologous HB-adMSCsPhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · Alzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · Rheumatoid ArthritisClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPhase 2 · Traumatic Brain InjuryClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsPancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
- HB-adMSCsSpinal Cord Injury at C5-C7 LevelClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney InjuryPHASE1_PHASE2 · RECRUITING · started Feb 1, 2026ClinicalTrials.gov NCT06654193 · fetched Nov 12, 2026
- Autologous Adipose-Derived Mesenchymal Stem Cells for Chronic Traumatic Brain InjuryPHASE2 · RECRUITING · started Apr 16, 2024ClinicalTrials.gov NCT05951777 · fetched Nov 12, 2026
- A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy (HB-adMSCs) for the Treatment of Alzheimer's DiseasePHASE1_PHASE2 · WITHDRAWN · started Mar 1, 2020ClinicalTrials.gov NCT04228666 · fetched Nov 12, 2026
- A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic EncephalopathyPHASE1_PHASE2 · COMPLETED · started Jan 1, 2020ClinicalTrials.gov NCT04063215 · fetched Nov 12, 2026
- Phase 1/2a Clinical Trial to Assess the Safety of HB-adMSCs for the Treatment of Rheumatoid ArthritisPHASE1_PHASE2 · COMPLETED · started Sep 25, 2018ClinicalTrials.gov NCT03691909 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cells for Treatment of SCINO_LONGER_AVAILABLEClinicalTrials.gov NCT03925649 · fetched Nov 12, 2026
- Individual Patient Expanded Access IND of Hope Biosciences First Blood Relative Allogeneic Adipose-derived Mesenchymal Stem Cells (HB-adMSCs) for Pancreatic CancerNO_LONGER_AVAILABLEClinicalTrials.gov NCT04087889 · fetched Nov 12, 2026